Splenic marginal zone lymphoma (SMZL) is a newly recognized lymphoma type whose
precise molecular pathogenesis is still essentially unknown. This hampers differential …

Splenic marginal zone lymphoma (SMZL) is an indolent small B-cell lymphoma involving the
spleen and bone marrow characterized by a micronodular tumoral infiltration that replaces …

Splenic marginal zone lymphoma (SMZL) is an indolent B cell malignancy usually involving
spleen, bone marrow and blood. The disease presents as an incidental finding or with …

Splenic marginal zone lymphoma is a small B-cell neoplasm whose molecular pathogenesis
is still essentially unknown and whose differentiation from other small B-cell lymphomas is …

Splenic marginal zone lymphoma (SMZL) is a recently described and distinctive type of
splenic lymphoma and is characterized by an indolent clinical course. By analyzing a large …

Immunoglobulin gene usage and somatic mutation patterns were studied in 59 patients with
splenic marginal zone lymphoma and were correlated with clinical characteristics. Fifty-nine …

Splenic marginal zone lymphoma (SMZL) is a B-cell neoplasm whose molecular
pathogenesis remains fundamentally unexplained, requiring more precise diagnostic …

Background Splenic marginal zone lymphoma (SMZL) is an indolent B-cell non-Hodgkin
lymphoma and represents the most common primary malignancy of the spleen. Its precise …

Splenic marginal zone B-cell lymphoma (SMZL) is a heterogeneous clinico-biological entity.
The clinical course is variable, multiple genes are mutated with no unifying mechanism, and …

Splenic marginal zone lymphoma (SMZL) is a rare B-cell malignancy involving the spleen,
bone marrow, and frequently the blood. SMZL lymphomagenesis involves antigen and/or …